Resumen

VAZQUEZ-AVILA, José Armando; ZETINA-MARTINEZ, Michael  y  DUARTE-MOTE, Jesús. Hyperuricemia and systemic arterial hypertension: what is the relationship?. Med. interna Méx. [online]. 2018, vol.34, n.2, pp.278-287. ISSN 0186-4866.  https://doi.org/10.24245/mim.v34i2.1613.

Uric acid is the end product of purine metabolism, ultimately converted to uric acid. There is no universal definition of hyperuricemia, in practice, the cutoff point is from 6.8mg/dL in plasma. The relationship between hyperuricemia and hypertension has been demonstrated in many experimental studies. Experimental studies have shown a linear positive correlation between blood pressure and uric acid levels, as well as a decrease in blood pressure figures with therapy with allopurinol. Numerous mechanisms have been identified through which hyperuricemia can cause hypertension: reduction of endothelial nitric oxide levels, stimulation of oxidative stress, expression in smooth muscle cells of the vascular endothelium of URAT-1 receptor, activation of the renin-angiotensin axis, stimulation of vascular smooth muscle proliferation also favors the development of renal microvascular disease. Recent evidence has provided new insight into the multiple mechanisms through which UA would play a major role both in systemic arterial hypertension and in multiple metabolic alterations; however, large-scale, well-designed clinical studies are needed, which prove more conclusively these theories, before considering therapies focused on the management of asymptomatic hyperuricemia in daily clinical practice

Palabras llave : Uric acid; Hyperuricemia; Hypertension; Allopurinol.

        · resumen en Español     · texto en Español     · Español ( pdf )